| JXSL1900073 | BAN2401 | lecanemab | Injection | Biological Products | Import Drug Application | 2019-08-24 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2019-08-23 | view |
| JXHL2100094 | Dotinurad片 | dotinurad | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL2100095 | Dotinurad片 | dotinurad | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL1800158 | E2006 | lemborexant | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2018-11-14 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2018-11-13 | view |
| JXHL1800157 | E2006 | lemborexant | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2018-11-14 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2018-11-13 | view |
| JXHL1900351 | E7090片 | tasurgratinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-12-14 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2019-12-13 | view |
| JXHB2100028 | E7090片 | tasurgratinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-23 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-22 | view |
| J0300220 | 依巴司汀片 | ebastine | Tablet | Chemical Drugs | Supplementary Application | 2003-08-21 | 卫材（中国）药业有限公司 | Eisai China Inc | Pending Approval | 2005-05-10 | view |
| J0300219 | 依巴司汀片 | ebastine | Tablet | Chemical Drugs | Supplementary Application | 2003-08-21 | 卫材（中国）药业有限公司 | Eisai China Inc | Pending Approval | 2005-05-10 | view |
| J0300221 | 依巴斯汀片 | ebastine | Tablet | Chemical Drugs | License Renew | 2003-08-21 | | Eisai China Inc | Certificate Issued | 2004-03-23 | view |
| J0300222 | 依巴斯汀片 | ebastine | Tablet | Chemical Drugs | License Renew | 2003-08-21 | | Eisai China Inc | Certificate Issued | 2004-03-23 | view |
| JXHL2100086 | 吡仑帕奈口服混悬液 | Perampanel | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2021-03-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-12 | view |
| JXHL1300327 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs | Import Drug Application | 2013-08-21 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2015-12-25 | view |
| JXHS2000156 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
| JYHB2001713 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-09-08 | 卫材（中国）药业有限公司 | Eisai China Inc | Filed | 2020-09-18 | view |
| JXHL2000090 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-05-11 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-05-10 | view |
| JXHS2000155 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
| JXHL2000086 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-04-28 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-04-27 | view |
| JXHS1800053 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2018-10-17 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2019-10-15 | view |
| JXHS2000154 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
